Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Synapse (New York, N.Y.)
|
April 26, 2008
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat
Anna R Carta, Lucia Frau, Frau Lucia, et al.
British Journal of Pharmacology
|
March 24, 2018
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models
Daniela Lecca, Elzbieta Janda, Giovanna Mulas, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
May 28, 2005
[Intellectual quotient and environmental exposure to low doses of lead]
P Carta, R Carta, E Girei, et al.
Experimental Neurology
|
October 5, 2016
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease
Giovanna Mulas, Elena Espa, Sandro Fenu, et al.
Experimental Neurology
|
December 13, 2023
Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study
Maria Francesca Manchinu, Mauro Pala, Maria Francesca Palmas, et al.
International Journal of Molecular Sciences
|
November 17, 2020
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi, Augusta Pisanu, Maria Francesca Palmas, et al.
Journal of Neurology
|
July 10, 2024
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells
Ana Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli, et al.
Cell Death Discovery
|
November 28, 2025
Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomers
Chiara Burgaletto, Anna Flavia Cantone, Maria Francesca Palmas, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Cells
|
September 9, 2022
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex
Maria Francesca Palmas, Michela Etzi, Augusta Pisanu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Synapse (New York, N.Y.)
|
April 26, 2008
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat
Anna R Carta, Lucia Frau, Frau Lucia, et al.
British Journal of Pharmacology
|
March 24, 2018
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models
Daniela Lecca, Elzbieta Janda, Giovanna Mulas, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|
May 28, 2005
[Intellectual quotient and environmental exposure to low doses of lead]
P Carta, R Carta, E Girei, et al.
Experimental Neurology
|
October 5, 2016
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease
Giovanna Mulas, Elena Espa, Sandro Fenu, et al.
Experimental Neurology
|
December 13, 2023
Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study
Maria Francesca Manchinu, Mauro Pala, Maria Francesca Palmas, et al.
International Journal of Molecular Sciences
|
November 17, 2020
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi, Augusta Pisanu, Maria Francesca Palmas, et al.
Journal of Neurology
|
July 10, 2024
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells
Ana Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli, et al.
Cell Death Discovery
|
November 28, 2025
Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomers
Chiara Burgaletto, Anna Flavia Cantone, Maria Francesca Palmas, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, et al.
Cells
|
September 9, 2022
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex
Maria Francesca Palmas, Michela Etzi, Augusta Pisanu, et al.
Page
of 9